Skip to content

To Study the Effect of SC-FOS Prebiotics in Women With Polycystic Ovary Syndrome

To Study the Clinical Effect of SC-FOS Prebiotics in Enteral Diet vs. Standard Enteral Diet on Clinical Characteristics of Patients With Polycystic Ovary Syndrome According to the Rotterdam Classification in Chihuahua, Chihuahua. A Randomized Single-Blind Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05999097
Enrollment
40
Registered
2023-08-21
Start date
2024-12-02
Completion date
2025-05-30
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Keywords

Polycystic Ovary Syndrome, Prebiotics, Enteral Diet, Clinical Manifestations, SC-FOS

Brief summary

The purpose of this study is to determine if there is a difference in the clinical characteristics of patients with polycystic ovary syndrome after the administration of SC-FOS in the enteral diet compared to patients with a standard diet.

Detailed description

The protocol will be discussed with the patients and/or relatives of the patients, who will understand the consequences and advantages of the study and will thus sign the consent. Once informed consent has been obtained, the group to which each patient belongs will be randomly assigned. Patients will be selected according to the inclusion and exclusion criteria of the population diagnosed with PCOS with useful enteral route for random assignment into two groups, one will be administered short-chain Fructooligosaccharides at a dose of 12 g every 24 hours, another group will be given saline as a placebo to the enteral diet every 24 hours for 10 days. Patients should take the solution on an empty stomach. Once the type of intervention has been determined, the patient will be given the suspensions corresponding to group 1 or placebo, with vials in which the content cannot be visualized, numbered according to the sheet obtained by the corresponding randomization. The initial evaluation will be completed with all the clinical characteristics to be evaluated. The patient will be told that every 24 hours he must take 1 suspension on an empty stomach, which will be prepared at a rate of 12 grams of SC-FOS in 15 cc of saline solution for the prebiotic preparation vs 15 cc of saline solution for the placebo group. The solution will be administered enterally for 10 consecutive days at a single dose per day, and a reassessment will be made on the seventh day of the clinical characteristics of the patients, to compare and evaluate the results.

Interventions

The intervention will receive Short-Chain Fructooligosaccharides at a dose of 12 gr. every 24 hours diluted in 250 ml of water.

DIETARY_SUPPLEMENTPlacebo Group

This group will receive 12 g of corn starch as a control group.

Sponsors

Universidad Autonoma de Chihuahua
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Single (Participant)

Intervention model description

Prospective study, randomized single blind clinical trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Female sex * Age 18 to 65 years * Polycystic Ovary Syndrome diagnosed by specialist * Useful enteral feeding

Exclusion criteria

* Pregnancy * Diabetes mellitus * Risk of intestinal perforation

Design outcomes

Primary

MeasureTime frameDescription
Score of Bristol Scale10 daysScore obtained by Stool Consistency Bristol Scale: This scale consist in seven types of stool: Type 1: Separate hard lumps, like nuts (difficult to pass) Type 2: Sausage-shaped, but lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage or snake, smooth and soft (average stool) Type 5: Soft blobs with clear cut edges Type 6: Fluffy pieces with ragged edges, a mushy stool (diarrhea) Type 7: Watery, no solid pieces, entirely liquid (diarrhea)
Score Short Form Health Survey (SF-36)10 daysShort Form Health Survey (SF-36) is a measure of health-related quality-of-life: It comprises 36 questions that cover eight domains of health 1. Limitations in physical activities because of health problems. 2. Limitations in social activities because of physical or emotional problems 3. Limitations in usual role activities because of physical health problems 4. Bodily pain 5. General mental health (psychological distress and well-being) 6. Limitations in usual role activities because of emotional problems 7. Vitality (energy and fatigue) 8. General health perceptions

Countries

Mexico

Contacts

Primary ContactCarolina Martinez Loya
caromtzloya@gmail.com6143543923
Backup ContactRuth Favela Ortiz
rfavelaortiz@gmail.com6142277559

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026